Navigation Links
IPA 7 Introduces Unique Contextual Search and Analysis Capabilities

REDWOOD CITY, Calif., Jan. 7 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced the release of IPA 7 with contextual data analysis. Contextual data analysis is comprised of a series of powerful biological filters and other tools that make it easier to quickly understand experimental results and fine- tune scientific hypotheses in relation to a particular experimental context or model.

Contextual data analysis enhances IPA's powerful search and analysis capabilities by enabling researchers to refine their experimental analyses and develop scientific hypothesis based on findings that have been demonstrated to occur in a particular species, cell types, tissues, bio-fluids, biological processes, cellular functions, chemicals, and disease of interest. For example, a CNS researcher can run an analysis and identify molecular interactions and gene to phenotype associations that have specifically been demonstrated in CNS tissues or cell lines -- effectively narrowing the hypothesis space to those most closely aligned with their experimental model.

Patrick De Boever, Ph.D., Flemish Institute for Technological Research (VITO), noted, "The new tools in IPA 7 are great for constructing species- specific biological interaction networks from our toxicogenomics data. This approach enabled us to reveal molecules that hold potential as blood biomarkers for neurotoxic effects induced by environmental pollutants."

Additional features have been added in IPA 7 to support researchers' workflows including:

    -- microRNA target information
    -- New Reporting Tools
    -- New Signaling Pathways
    -- Additional Chemical Content

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA's search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals (

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. Our long-term focus on innovation in semantic search has allowed us to create groundbreaking technologies that have one common goal -- to generate maximum value from all types of biological and chemical knowledge. Ingenuity offerings leverage the Ingenuity Knowledge Base, which contains uniquely structured literature findings that allow scientists to ask complex biological questions and gain rapid insight into their experimental data or systems of interest. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, academic, and government research institutions worldwide.

SOURCE Ingenuity Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... Diego, CA (PRWEB) , ... December 01, 2015 ... ... and scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... mobile imaging results enhancements at the Radiological Society of North America (RSNA) 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
Breaking Medicine Technology: